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Introduction
Sarcoidosis is a systemic inflammatory disease 
characterized by the formation of noncaseating 
granulomas. Most commonly it manifests as 
diseases of the pulmonary system, although it can 
involve any organ in the body. Hepatic involvement 
is well known and can present as abdominal pain, 
pruritus, hepatomegaly, and jaundice. Rarely does 
it progress to portal hypertension or cirrhosis. 
Hepatic sarcoidosis in the absence of pulmonary 
involvement is seen in less than 10% of cases. 
Here we highlight a case of isolated hepatic 
sarcoidosis discovered incidentally presenting  
as portal hypertension.
Case
A 47-year-old Caucasian male with past medical 
history of type 2 diabetes mellitus, essential 
hypertension, and alcohol abuse presented to the 
Emergency Department after a motor vehicle 
accident. Trauma workup including CT scan of the 
chest, abdomen, and pelvis incidentally showed 
scattered small pulmonary nodules, fatty liver, and 
splenomegaly with splenic varices. Subsequent 
outpatient MRI showed hepatosplenomegaly and 
portal hypertension. The patient was referred to 
gastroenterology for further evaluation. Abdominal 
ultrasound with doppler showed patent hepatic 
vessels and normal bile ducts. Initially, it was 
thought that the patient’s liver findings were 
secondary to fatty liver disease given risk factors 
of metabolic syndrome and daily alcohol use of 
6-8 beers per day. Labs were significant for 
thrombocytopenia with a platelet count of 129 
thou/cmm, normal albumin of 3.6 g/dL, normal 
liver function panel including total bilirubin 1.0 mg/
dL, AST 22 U/L, ALT 29 U/L, and AP 108 U/L, 
and normal INR of 1.1. Serologic testing for 
chronic liver disease was negative except for an 
elevated smooth muscle antibody 1:160 and 
serum immunoglobulin G 1827 g/L which were 
suggestive of autoimmune hepatitis. An EGD 
showed small esophageal varices and isolated 
gastric varices in the fundus. He ultimately 
underwent a percutaneous liver biopsy that 
showed noncaseating granulomas without 
significant fibrosis. There was no steatosis or 
features of autoimmune hepatitis. Stains for 
acid-fast bacilli and fungi were also negative.  
The patient was diagnosed with hepatic 
sarcoidosis presenting as non-cirrhotic portal 
hypertension. Other organ involvement was not 
found. He was started on nadolol for prophylaxis 
of gastroesophageal bleeding. Treatment for 
sarcoidosis was not initiated given the lack of 
clinical symptoms and normal liver enzymes.
Discussion
Our case demonstrates the importance of 
considering hepatic sarcoidosis as a cause of 
portal hypertension. Liver involvement is common 
in sarcoidosis, up to 70% of cases, but significant 
complications including cirrhosis and portal 
hypertension are rare, about 3%. Non-cirrhotic 
portal hypertension as seen in our case is pre-
sinusoidal and thought to be secondary to 
granuloma compression of the portal vein. Treatment 
is reserved for those with clinical symptoms with 
first line therapy being glucocorticoids. Alternatives 
include ursodeoxycholic acid, immunosuppressants, 
such as methotrexate and chlorambucil, and 
rarely liver transplant.
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Image 1. Histological slide showing liver specimen overview (100x).
Image 2. Histological slide showing liver granuloma (200x).
